医学
胰腺癌
成纤维细胞活化蛋白
PET-CT
放射科
正电子发射断层摄影术
氟脱氧葡萄糖
前列腺癌
胰腺
核医学
癌症
内科学
作者
Asha Kandathil,Rathan M. Subramaniam
出处
期刊:Pet Clinics
[Elsevier]
日期:2024-04-01
卷期号:19 (2): 163-175
被引量:1
标识
DOI:10.1016/j.cpet.2023.12.003
摘要
[18F] Fluorodeoxyglucose (18F-FDG) PET/CT can improve the staging accuracy and clinical management of patients with hepatobiliary and pancreatic cancers, by detection of unsuspected metastases. 18F-FDG PET/CT metabolic parameters are valuable in predicting treatment response and survival. Metabolic response on 18F-FDG PET/CT can predict preoperative pathologic response to neoadjuvant therapy in patients with pancreatic cancer and determine prognosis. Several novel non-FDG tracers, such as 68Ga prostate-specific membrane antigen (PSMA) and 68Ga-fibroblast activation protein inhibitor (FAPI) PET/CT, show promise for imaging hepatobiliary and pancreatic cancers with potential for radioligand therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI